Botox rivals are on the way, and to get out in front of them, Allergan is fielding a new ad push. Its aim: To get would-be users to ask for the blockbuster drug by name. Otherwise, they might get one ...

OKLAHOMA CITY – The drug has long been thought to be a quick and easy fix for wrinkles. Allergan BOTOX is approved by the FDA and commonly used by plastic surgeons, dermatologists, even dentists, to ...

Allergan’s latest target for Botox Cosmetic is millennials. If there's any doubt, just look at the crowd of 20-somethings in its newly launched TV ad: Young people exaggerate their facial ...

A pair of phase 3 trials of Revance Therapeutic’s RT002 have hit all their primary and secondary endpoints. The effect of the neuromodulator on wrinkles lasted for six months, suggesting it poses a ...

Allergan pushes "Botox parties" that put people at risk of HIV and hepatitis because a "single-use" vial of the drug is used multiple times on different guests, according to a federal lawsuit filed in ...

Allergan (AGN)'s $600 million settlement with the Department of Justice-- over illegally marketing Botox for unapproved uses such as headache -- looks bad for the company's pending application with ...

Gift Article 10 Remaining As a subscriber, you have 10 articles to gift each month. Gifting allows recipients to access the article for free. A federal jury July 18 said Revance Therapeutics' skin ...

Allergan has agreed to pay $195 million to acquire Bonti, a startup founded by former Allergan executives focused on creating a new botulinum neurotoxin. The Big Pharma will pick up global rights to ...